Bio/Pharma News

Janssen Alleges HyClone Lab Infringed its Cell-Culture Media Patent

June 17, 2016

In a lawsuit against Celltrion, Janssen alleges the GE subsidiary infringed one of Janssen’s patents covering the method of making the cell-culture media that HyClone later supplied to Celltrion.

Anthrax Vaccine Nabs Orphan Drug Status

June 16, 2016

A new indication for Emergent BioSolutions’ BioThrax will give the drug market exclusivity through November 2022.

Keytruda Proves Superior to Chemotherapy in Phase III Trials

June 16, 2016

Keytruda was shown to be superior to chemotherapy in the treatment of patients with non-small cell lung cancer.

Pfizer Builds Biologics Clinical Manufacturing Facility in Massachusetts

June 16, 2016

Pfizer broke ground at its Andover, Massachusetts campus on a clinical manufacturing facility for complex biologics and vaccines.

Merck to Acquire Afferent Pharmaceuticals

June 13, 2016

Merck will acquire Afferent Pharmaceuticals for $500 million in cash with the potential for additional payments.

Results Released from Ixekizumab Phase III Trials

June 10, 2016

In Phase III clinical trials, ixekizumab showed to be superior to etanercept and placebo in treating moderate-to-severe plaque psoriasis.

Alvotech Opens mAbs Biosimilar Facility in Iceland

June 10, 2016

Alvotech prepares for commercial biosimilar production in new facility with single-use bioreactors in Reykjavik, Iceland.

Fujifilm Diosynth Announces Collaboration With MSD on Large-Scale Biologics Facility

June 07, 2016

A new 20,000-L microbial biologics facility in Ireland will be operational by 2018 for Fujifilm Diosynth's contract development and manufacturing customers.

Amyris and Janssen Collaborate on Biosynthetic Drug Discovery

June 06, 2016

Amyris will use its platform technology to develop a library of natural and natural-like compounds to test against Janssen’s therapeutic target.

Mylan and Biocon’s Biosimilar to Herceptin Demonstrates Comparable Efficacy

June 06, 2016

Results of the HERITAGE study were announced at the 2016 American Society of Clinical Oncology meeting.